Texas Oncology Central South (SCRI) — Austin, Texas

Texas Oncology Central South (SCRI) is a clinical research site located in Austin, Texas, United States 78705.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Texas Oncology Central South (SCRI) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Gastroesophageal-junction Cancer, Monoclonal Antibody, Gastric Cancer.

Sponsors: Shanghai Henlius Biotech.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology Central South (SCRI)?

Texas Oncology Central South (SCRI) has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology Central South (SCRI) conducted?

Texas Oncology Central South (SCRI) has 1 clinical trials on record, with 1 currently active. Their work covers Gastroesophageal-junction Cancer, Monoclonal Antibody, Gastric Cancer.

Is Texas Oncology Central South (SCRI) accredited by Crixeo Health?

Texas Oncology Central South (SCRI) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Texas Oncology Central South (SCRI)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.